Skip to content
Arab World Edition
العربية Claim your profile
Executive profile

Khalid Nabilsi Verified

خالد النابلسي
Deputy CEO, North America and Europe, Hikma Pharmaceuticals PLC
Suggest an update Is this you? Claim this profile
Industries
Healthcare
Record status: Editorially verified Last verified: 1 Oct 2026 Last updated: 22 Oct 2026 Sources: 3

Biography

Khalid Nabilsi is Chief Financial Officer of Hikma Pharmaceuticals and joined its Board of Directors in December 2025, taking on expanded management duties to support strategic execution.

Current positions

Deputy CEO, North America and Europe
Hikma Pharmaceuticals PLC
Chief Financial Officer
Hikma Pharmaceuticals PLC

Board positions

2025 – Present

Career timeline

  1. 2025 – Present
    Board member
    Hikma Pharmaceuticals PLC
  2. Current
    Deputy CEO, North America and Europe
    Hikma Pharmaceuticals PLC
  3. Current
    Chief Financial Officer
    Hikma Pharmaceuticals PLC

Executive moves

News & interviews

Analysis

Executive moves across the Gulf: 29 sourced appointments and departures

Who took which chair, and who is about to, by country, from the company announcements and exchange filings behind each record.

Sources

  1. 1. Hikma Pharmaceuticals CEO Riad Mishlawi steps down, Executive Chairman assumes role (15 Dec 2025) DirectorsTalk Interviews · read 5 Sep 2026 Supports: profile
  2. 2. Arabic name: Al Bayan Al Bayan · read 5 Sep 2026 Supports: profile
  3. 3. Leadership - Hikma Hikma Pharmaceuticals · read 1 Oct 2026 Supports: Deputy CEO, North America and Europe, Hikma Pharmaceuticals PLC “Khalid Nabilsi, Deputy CEO, North America and Europe”